Patients should discuss any additional medications or supplements with their healthcare provider before starting them, as some interactions may affect diabetes control or medication absorption
Kan ekerini Dzenlemek: Pankreastan inslin salnmn artrarak kan ekerini kontrol altnda tutarlar
Patients should never stop or adjust their medication without first consulting the prescribing clinician or trial investigator, as abrupt discontinuation may affect metabolic control and overall health outcomes
Diabetes Care 34:S258S263 Portha B, Tourrel-Cuzin C, Movassat J (2011) Activation of the GLP-1 receptor signalling pathway: a relevant strategy to repair a deficient beta-cell mass
Study B The efficacy of TRESIBA was evaluated in a 26-week randomized, open-label, multicenter trial in 455 patients with type 1 diabetes mellitus (Study B)
This timing allows the liposomal delivery system to enter the bloodstream without interference from dietary fats or proteins